X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
oncology (9) 9
female (8) 8
adult (7) 7
male (7) 7
analysis (6) 6
cancer (6) 6
index medicus (6) 6
prognosis (6) 6
aged (5) 5
middle aged (5) 5
genetic aspects (4) 4
genetic research (4) 4
hematology (4) 4
karyotyping (4) 4
research (4) 4
acute renal failure (3) 3
aged, 80 and over (3) 3
bcr (3) 3
chronic myelogenous leukemia (3) 3
chronic myeloid leukemia (3) 3
cytogenetics (3) 3
epidemiology (3) 3
genetics & heredity (3) 3
germline mutation (3) 3
hematology, oncology and palliative medicine (3) 3
imatinib (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - genetics (3) 3
medicine & public health (3) 3
renal lymphoma (3) 3
retrospective studies (3) 3
tunisia (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
chromosome 9 (2) 2
chromosome deletion (2) 2
chromosome translocations (2) 2
chromosomes, human, pair 22 - genetics (2) 2
chromosomes, human, pair 9 - genetics (2) 2
chronic myelocytic-leukemia (2) 2
dna methylation (2) 2
familial hematological malignancies (2) 2
fluorescence (2) 2
fluorescence in situ hybridization (2) 2
fusion proteins, bcr-abl - genetics (2) 2
gene mutations (2) 2
genes (2) 2
genetics (2) 2
hematologic neoplasms - genetics (2) 2
hematological familial malignancies (2) 2
in situ hybridization, fluorescence (2) 2
in-situ hybridization (2) 2
leukemia, lymphocytic, chronic, b-cell - diagnosis (2) 2
leukemia, lymphocytic, chronic, b-cell - drug therapy (2) 2
life sciences (2) 2
lymphoma (2) 2
medical education (2) 2
molecular genetics (2) 2
mutation (2) 2
myelodysplastic syndromes - genetics (2) 2
oncology, experimental (2) 2
philadelphia chromosome (2) 2
poor-prognosis (2) 2
risk (2) 2
survival (2) 2
survival analysis (2) 2
translocation, genetic - genetics (2) 2
9q34 (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[ sdv.gen ] life sciences [q-bio]/genetics (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
[sdv.gen]life sciences [q-bio]/genetics (1) 1
[sdv.mhep]life sciences [q-bio]/human health and pathology (1) 1
abl gene (1) 1
acute kidney injury - etiology (1) 1
acute leukemia (1) 1
acute lymphoblastic leukemia (1) 1
acute lymphoblastic-leukemia (1) 1
acute myeloid leukemia (1) 1
acute-leukemia (1) 1
adolescent (1) 1
age factors (1) 1
anemia, refractory, with excess of blasts - etiology (1) 1
antigens, cd20 - blood (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents/adverse effects (1) 1
antineoplastic agents/therapeutic use (1) 1
apoptosis (1) 1
apoptosis - genetics (1) 1
b-cell lymphoma (1) 1
bcr/abl rearrangement (1) 1
benzamides (1) 1
biology (1) 1
biomarkers, tumor - blood (1) 1
biomedicine (1) 1
biomedicine, general (1) 1
biopsy (1) 1
breakpoints (1) 1
breast cancer (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Hematology, ISSN 0939-5555, 4/2018, Volume 97, Issue 4, pp. 597 - 604
Data are limited in developing countries regarding the clinicopathologic features and response to therapy of chronic myeloid leukemia (CML) in the era of... 
Imatinib | Survey | CML | Medicine & Public Health | Hematology | Oncology | Management | Tunisia | Clinical practice | SURVIVAL | INTERFERON | CHRONIC-PHASE | RECOMMENDATIONS | HEMATOLOGY | EUROPEAN-LEUKEMIANET | Antimitotic agents | Chronic myeloid leukemia | Antineoplastic agents | Epidemiology | Patient outcomes | Analysis | Multivariate analysis | Medical prognosis | Leukemia | Developing countries--LDCs | Index Medicus | Tumor Burden/drug effects | Leukemia, Myeloid, Chronic-Phase/epidemiology | Prognosis | Splenomegaly/prevention & control | Follow-Up Studies | Leukemia, Myeloid, Accelerated Phase/epidemiology | Middle Aged | Humans | Antineoplastic Agents/therapeutic use | Child, Preschool | Male | Practice Patterns, Physicians | Splenomegaly/pathology | Young Adult | Life Sciences | Leukemia, Myeloid, Chronic-Phase/pathology | Aged, 80 and over | Adult | Antineoplastic Agents/adverse effects | Female | Retrospective Studies | Child | Tunisia/epidemiology | Leukemia, Myeloid, Accelerated Phase/pathology | Leukemia, Myeloid, Chronic-Phase/diagnosis | Leukemia, Myeloid, Chronic-Phase/drug therapy | Splenomegaly/etiology | Human health and pathology | Protein Kinase Inhibitors/adverse effects | Leukemia, Myeloid, Accelerated Phase/drug therapy | Imatinib Mesylate/therapeutic use | Leukemia, Myeloid, Accelerated Phase/diagnosis | Adolescent | Protein Kinase Inhibitors/therapeutic use | Survival Analysis | Imatinib Mesylate/adverse effects | Aged
Journal Article
Journal Article
Nephrologie et Therapeutique, ISSN 1769-7255, 04/2010, Volume 6, Issue 2, pp. 132 - 136
Acute renal failure, as the initial manifestation of lymphoma, has been reported only in a few cases. In this work, we report the case of a 28-year-old women... 
Renal lymphoma | Acute renal failure
Journal Article
Néphrologie & Thérapeutique, ISSN 1769-7255, 04/2010, Volume 6, Issue 2, pp. 132 - 136
L’insuffisance rénale aiguë est rarement secondaire à une prolifération tumorale maligne infiltrant les reins. Nous rapportons le cas d’une femme de 28 ans,... 
Insuffisance rénale aiguë | Renal lymphoma | Lymphome rénal | Acute renal failure
Journal Article
Journal Article
La Tunisie medicale, ISSN 0041-4131, 04/2003, Volume 81, Issue 4, p. 226
Journal Article
Medical Oncology, ISSN 1357-0560, 6/2012, Volume 29, Issue 2, pp. 1151 - 1160
The aims of this study are to investigate the frequency of derivative chromosome 9 (der (9)) deletion in Tunisian patients with chronic myeloid leukemia (CML)... 
Imatinib | Deletion on derivative chromosome 9 | Hematology | Cytogenetic response | Internal Medicine | Oncology | Hydroxyurea | Chronic myeloid leukemia | Variant Philadelphia rearrangement | Philadelphia chromosome | Pathology | Medicine & Public Health | Fluorescence in situ hybridization | CHRONIC MYELOGENOUS LEUKEMIA | DER DELETIONS | IN-SITU HYBRIDIZATION | SUBMICROSCOPIC DELETIONS | BCR | ONCOLOGY | ABL GENE | POOR-PROGNOSIS | FISH | T(9/22) | IMATINIB MESYLATE THERAPY | Piperazines - administration & dosage | Prognosis | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Chromosomes, Human, Pair 22 - genetics | Chromosomes, Human, Pair 9 - genetics | Karyotyping | Adult | Female | Retrospective Studies | Philadelphia Chromosome | Chromosome Deletion | DNA Probes | Proto-Oncogene Proteins c-abl - genetics | Pyrimidines - administration & dosage | Hydroxyurea - administration & dosage | In Situ Hybridization, Fluorescence | Imatinib Mesylate | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins c-bcr - genetics | Benzamides | Translocation, Genetic - genetics | Medical research | Molecular genetics | Oncology, Experimental | Fluorescence | Research | Myelocytic leukemia | Analysis | Cytogenetics | Medicine, Experimental | Genetic research | Genetic aspects | Nonlymphoid leukemia | Chromosomes | Cancer | Chromosome translocations | Interphase | Karyotypes | Chromosome deletion | Fluorescent indicators | chromosome 9
Journal Article
Cancer Genetics and Cytogenetics, ISSN 0165-4608, 2009, Volume 194, Issue 1, pp. 30 - 37
Journal Article
Hereditary Cancer in Clinical Practice, ISSN 1897-4287, 09/2011, Volume 9, Issue 1, p. 9
Perforin gene (PRF1) mutations have been identified in some patients diagnosed with the familial form of hemophagocytic lymphohistiocytosis (HLH) and in... 
Life Sciences | Genetics | Cancer
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5827 - 5827
Abstract Background: High dose Melphalan (HDM) and autologous stem cell transplantation (ASCT) is a standard care for Myeloma ≤ 65 years. Studies have... 
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.